News &amp; Updates

A short-term treatment regimen based on high-dose gatifloxacin appears to be effective against multidrug- or rifampicin-resistant tuberculosis (TB) but at the cost of increased severe adverse drug reactions, as shown in a study.

Short-course, high-dose gatifloxacin gets a pass in multidrug-resistant TB with caveat

08 Dec 2021

Botox injection achieves successful motor alignment in patients with strabismus

Extraocular muscle injection of botulinum toxin type A (BTXA) results in a high rate of successful motor alignment, which is similar to that achieved following eye muscle surgery for nonparalytic, nonrestrictive horizontal strabismus, reports a recent study.

Botox injection achieves successful motor alignment in patients with strabismus

Ixekizumab effective for difficult-to-treat psoriatic arthritis

The monoclonal antibody ixekizumab improved the signs and symptoms of psoriatic arthritis (PsA) in PsA patients with inadequate response to one or two tumour necrosis factor inhibitors (TNFis), suggests results from a post hoc subanalysis of the SPIRIT-P2 trial.

Ixekizumab effective for difficult-to-treat psoriatic arthritis

08 Dec 2021

Air pollution responsible for thousands of deaths yearly: study

Despite significant progress in controlling air pollution, it remains an urgent public health problem, according to a recent European study, which found that more than 300,000 deaths in the region could be attributed to air pollution in 2019.

Air pollution responsible for thousands of deaths yearly: study

Breast cancer: Dense breasts may spell trouble for menopausal women

An extremely dense breast prior to and after menopause may double the risk of breast cancer, according to a Korean cohort study.

Breast cancer: Dense breasts may spell trouble for menopausal women

08 Dec 2021

AECOPD outcomes unaltered with short-course nonmacrolide therapy

Short-course nonmacrolide therapy in patients with acute exacerbations of chronic obstructive pulmonary disease (AECOPD) appears to have no significant effect on outcomes including mortality, progression to ventilation, readmission rate, or prevalence of adverse drug events, a study has shown.

AECOPD outcomes unaltered with short-course nonmacrolide therapy

08 Dec 2021

Management of ATTR-CM with tafamidis: Challenges and opportunities

The advent of tafamidis ushers in a promising new era in the treatment and management of transthyretin amyloid cardiomyopathy (ATTR-CM), with longer-term clinical data attesting to its efficacy and safety. Despite this, ATTR-CM remains an easily overlooked and potentially fatal cause of heart failure. Furthermore, its elusive diagnosis often results in late or misdiagnosis. Clinical Assistant Professor Tang Hak Chiaw, Senior Consultant with the Department of Cardiology at the National Heart Centre Singapore, speaks on the challenges and opportunities on the diagnosis and management of ATTR-CM patients while sharing his experience of using tafamidis.

Management of ATTR-CM with tafamidis: Challenges and opportunities

Increased serum iron may hint at HCC risk in NAFLD patients

07 Dec 2021 by

Increased serum iron or transferrin saturation levels in individuals with non-alcoholic fatty liver disease (NAFLD) may point to an increased risk of hepatocellular carcinoma (HCC), according to a study presented at The Liver Meeting Digital Experience™.

Increased serum iron may hint at HCC risk in NAFLD patients

Thicker subcutaneous fat during pregnancy ups pre-eclampsia risk

Higher subcutaneous adipose tissue thickness during the second trimester, measured using ultrasound, appears to increase the risk of pre-eclampsia, a recent study has found.

Thicker subcutaneous fat during pregnancy ups pre-eclampsia risk

Let there be light: Repeated red-light therapy feasible for myopia control in kids

07 Dec 2021 by

Repeated, direct delivery of light on the retina can put brakes on axial elongation and myopic refraction progression in children with nearsightedness, according to a team of investigators from China.

Let there be light: Repeated red-light therapy feasible for myopia control in kids